跳至主要内容
临床试验/JPRN-UMIN000043459
JPRN-UMIN000043459已完成未知

Anticoagulation, Risk of Bleeding, and Overall mortality in Hospitalized Patients with COVID-19: A Meta-Analysis - Anticoagulation, Risk of Bleeding, and Overall mortality in Hospitalized Patients with COVID-19: A Meta-Analysis

Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia0 个研究点目标入组 2,506 人开始时间: 2021年2月27日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
2,506

研究概览

简要总结

MWH administration was associated with a lower in-hospital mortality, and 28/30-day mortality compared with UFH administration. However, there was no difference in the incidence of bleeding with LMWH compared with UFH.

研究设计

研究类型
Others,meta-analysis etc

入排标准

年龄范围
18years-old 至 90years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • missing required data, no data on anticoagulant use, no outcome of interest, other than english language

研究者

发起方
Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia

相似试验